Psilera
PrivateLast Round
Seed
May 28, 2026
Total Funding Raised
$13.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Psilera operates in Healthcare & Life Sciences and is based in Tampa, Florida. Its latest recorded funding round was a Seed round in May 2026.
Psilera is a biotechnology company that develops groundbreaking first-in-class treatments for neurological disorders by creating a new class of next-generation neuroplastogens.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Psilera Comparables
Compare Psilera with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Xylo Bio | 79% | |
| Exin Therapeutics | 79% | |
| VCENNA | 79% |
For institutional investors. Book with your work email.
Psilera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 28, 2026 | ||||
| Grant | Oct 2, 2025 | ||||
| Grant | Sep 5, 2024 | ||||
| Seed | Jul 1, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Psilera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Baird Inc. | Seed |
| Receptor Partners | Seed |
| NIH RADx | Grant |
| Iter Investments | Seed |
| National Institute on Alcohol Abuse and Alcoholism | Grant |
| University of South Florida Research Foundation | Grant, Seed |
| What If Ventures | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 87% MoM.
- May 28, 2026
$9M raised in Seed funding.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 8, 2026
In Florida in Oct '26, Psilera is developing non-hallucinogenic derivatives of psilocybin with University of South Florida researchers as part of the second phase of NIH-funded research; the derivatives could reduce alcohol consumption without producing a psychedelic trip, with a Phase 1a human clinical trial anticipated in 2027.
- hiresAug 27, 2026
Psilera appoints Allyson Gage, PhD, as Vice President, Clinical Development in Florida on Aug 27th '26, where she oversees the clinical development strategy and operational execution of its upcoming Phase 1 first-in-human trials of PSIL-006.
For institutional investors. Book with your work email.
Psilera Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Psilera's valuation, stock price, and market status.
Is Psilera a public or private company?
Psilera is a private company.
What is the current stock price of Psilera?
Psilera is a private company, so its shares have no public market price. Caplight tracks Psilera's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Psilera worth (valuation)?
Valuation information for Psilera is not publicly available.
Can I buy Psilera stock?
Psilera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Psilera's last funding round?
Psilera's most recent funding round was Seed on May 28, 2026.
Who are the main investors in Psilera?
Key investors in Psilera include Iter Investments.
Will Psilera IPO soon?
No public IPO plans have been announced for Psilera.
How can I track Psilera secondary market activity?
Caplight tracks bids, offers, and trades in Psilera's shares on secondary markets.